Senate Bill S9322

                                 
BILL NUMBER: S9322          Revised 3/2/2026

SPONSOR: PALUMBO
 
TITLE OF BILL:

An act to amend the public health law, in relation to adding 7-Hydroxym-
itragynine to the schedule of controlled substances

 
PURPOSE:

To add 7-Hydroxymitragynine (7-0H) in its pure state along with enhanced
or synthesized 7-0H products to the Schedule 1 list of controlled
substances.

 
SUMMARY OF PROVISIONS:

Section 1. Subdivision (b) of schedule I of section 3306 of the public
health law is amended by adding a new paragraph 93 to read as follows:
7-Hydroxymitragynine including its salts, isomers and salts of isomers,
whenever the existence of such sales, isomers and salts of isomers is
possible within the specific chemical designation.

              

Section 2. Sets for the effective date.

 
JUSTIFICATION:

Concentrated 7-0H has been shown to be up to 13 times stronger than
morphine in binding to opioid receptors in the body. While it occurs
naturally in the kratom plant, in these natural leaves it makes up less
than 2% of the total alkaloids. Concerning products contain isolated or
semi-synthetic 7-0H in much higher concentrations (up to 98%)

7-0H products are not FDA approved for any medical use and are illegal
under federal law as a food additive or dietary supplement, In July
2025, the FDA recommended that the Drug Enforcement Administration (DEA)
classify 7-0H as a controlled substance.

These products are often sold in gas stations, vape shops and online,
packaged deceptively as gummies, candies or liquid shots, making them
appealing and accessible to children and teens.

By placing 7-Hydroxymitragynine on the schedule I of controlled
substances, unauthorized possession, manufacturing or distribution of
these products will carry the most severe penalties.

 
LEGISLATIVE HISTORY:

New bill

 
FISCAL IMPLICATIONS:

 
EFFECTIVE DATE:
Immediately